Sign up for free insights newsletter
BA

Baxter International Inc

BAXUnited States

Need professional-grade analysis? Visit stockanalysis.com

$16.72
+3.53%
End of day
Market Cap

$8.95B

P/E Ratio

N/A

Employees

37,500

Dividend Yield

2.89%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.06-1.26-1.26-1.21
Calmar-1.72-1.55-0.98-1.36
Sharpe-0.87-1.06-1.07-1.02
Omega0.810.770.770.78
Martin-5.06-2.90-1.63-2.91
Ulcer9.3117.3131.5721.25

Baxter International Inc (BAX) Price Performance

Baxter International Inc (BAX) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $16.72, up 3.53% from the previous close.

Over the past year, BAX has traded between a low of $16.15 and a high of $33.79. The stock has lost 49.2% over this period. It is currently 50.5% below its 52-week high.

Baxter International Inc has a market capitalization of $8.95B and a dividend yield of 2.89%.

About Baxter International Inc

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$10.36B
EBITDA
$2.02B
Profit Margin
-8.51%
EPS (TTM)
-1.75
Book Value
11.92

Technical Indicators

52 Week High
$34.07
52 Week Low
$16.08
50 Day MA
$19.99
200 Day MA
$22.92
Beta
0.55

Valuation

Trailing P/E
N/A
Forward P/E
9.02
Price/Sales
0.80
Price/Book
1.46
Enterprise Value
$25.68B